News - Allergan, Research

Filter

Current filters:

AllerganResearch

Popular Filters

Allergan and Medytox collaborate on neurotoxins

28-09-2013

Allergan has entered into a license agreement with Medytox which will see Allergan pay Medytox $65 million…

AllerganGlobalLicensingMedytoxPharmaceuticalResearch

Spectrum regains rights from Allergan for apaziquone

03-02-2013

US biotech firm Spectrum Pharmaceuticals (NasdaqGS: SPPI) says it has reacquired development and commercialization…

AllerganapaziquoneBiotechnologyLicensingOncologyResearchSpectrum Pharmaceuticals

Migraine drug sales to grow to $5.8 billion in 2021 in major markets

18-11-2012

Despite a decline in sales owing to the generic entry of most triptans, the launch of emerging acute…

AllerganBotoxCoLucidGenericsGloballasmiditanLevadexMAP PharmaceuticalsMarkets & MarketingPharmaceuticalResearch

Botox shows efficacy in idiopathic overactive bladder, says Allergan

29-03-2012

USA-based Allergan (NYSE: AGN) announced that two Phase III clinical trials of Botox (onabotulinumtoxinA),…

AllerganBotoxGenito-urinaryPharmaceuticalRegulationResearch

Back to top